1. Home
  2. PGEN vs CUBI Comparison

PGEN vs CUBI Comparison

Compare PGEN & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.70

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$78.87

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
CUBI
Founded
1998
1994
Country
United States
United States
Employees
47
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
PGEN
CUBI
Price
$7.70
$78.87
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
$8.33
$85.00
AVG Volume (30 Days)
3.7M
201.8K
Earning Date
05-13-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.99
EPS
0.03
4.02
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$24.95
Revenue Next Year
$81.04
$9.50
P/E Ratio
$258.83
$19.29
Revenue Growth
N/A
N/A
52 Week Low
$2.99
$59.34
52 Week High
$8.04
$84.38

Technical Indicators

Market Signals
Indicator
PGEN
CUBI
Relative Strength Index (RSI) 64.70 49.94
Support Level $6.57 $74.77
Resistance Level $7.72 $79.99
Average True Range (ATR) 0.27 1.83
MACD 0.05 -0.04
Stochastic Oscillator 76.41 58.85

Price Performance

Historical Comparison
PGEN
CUBI

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.

Share on Social Networks: